NCT07007572 Evaluation Of Marginal Bone Height Changes And Biting Force In Screw Retained Implant Prostheses Using Reinforced Resin Vs Monolithic Zirconium
| NCT ID | NCT07007572 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Cairo University |
| Condition | Biting Forces |
| Study Type | INTERVENTIONAL |
| Enrollment | 14 participants |
| Start Date | 2024-12-31 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
In Phase 2, researchers evaluate early signs of effectiveness. You may be randomized to receive the active treatment or a comparator. Monitoring continues closely.
This trial targets 14 participants in total. It began in 2024-12-31 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This studies aims to compare the behavior of recently introduced resin reinforces compared to monolithic zirconia
Eligibility Criteria
Inclusion Criteria: * Mandibular Class II, partially edentulous patients that enables measuring the marginal bone height changes and values of biting forces intra-orally. * Fully dentulous edentulous opposing Maxillary arch. * Patients with normal class I jaw relationship. * Patients that require fixed restorations for functional and esthetic reasons * Age range (30-60 years). * Cooperative patients those are willing to attend all follow-up periods. * Patients with healthy attached mucosa of appropriate thickness free from any inflammation. * Patients with healthy bone of appropriate thickness, width and height free from any inflammation. * Patients without any medical conditions that contraindicates implant placement. Exclusion Criteria: * Patients with Parkinson's disease * Patients with xerostomia. * Patients with a history of allergy to resins and/ or zirconia. * Patients with a medical systematic condition that contraindicate implant placement. * Patients smoking more than 10 cigarettes per day. * Patients with pathological changes of residual ridges as recurrent or persistent ulcers, osteomyelitis and infections. * Patients with large irregular bony exostosis. * Patients with medical or psychological conditions as physical disability or mental retardation that hinder cooperation in the follow up visits and answering the questionnaires.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07007572 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Biting Forces. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07007572 trial and what does that mean for participants?
Phase 2 trials evaluate whether the treatment shows signs of effectiveness while continuing to monitor safety. More participants are enrolled than in Phase 1 to help refine the treatment protocol.
Is NCT07007572 currently recruiting?
Yes, NCT07007572 is actively recruiting participants. Contact the research team at mahmoud.fayed@dentistry.cu.edu.eg for enrollment information.
Where is the NCT07007572 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT07007572 clinical trial?
NCT07007572 is sponsored by Cairo University. The trial plans to enroll 14 participants.